
Marios Giannakis
Assistant Professor of Medicine Dana Farber Cancer Institute · Harvard School of Public Health
Credentials: · · · ·
History
Research
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Science · 2018 · 999 citations
Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Nature · 2020 · 982 citations
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Gut · 2016 · 872 citations

95 papers

83 papers · 10 as a fellow

72 papers

67 papers

58 papers
- CF
45 papers

32 papers
- AS
Annacarolina Fabiana Lucia Da Silva
22 papers · 16 as a resident
Grants
- 2024–2028
Harnessing DNA Methylation in Peripheral Blood for Improved Colorectal Cancer Prevention
National Cancer Institute · R01
PI · $2M · Harvard University d/b/a Harvard School of Public Health
- 2018–2020
National Cancer Institute · R21
PI · $177.7K · Harvard University d/b/a Harvard School of Public Health
Clinical trials
- 2018–2022
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Site PI · Unknown · Phase 2
Massachusetts General Hospital
- 2016–2023
Site PI · Unknown · Phase 1
Curegenix Inc.


